docetaxel anhydrous has been researched along with Cancer of Pharynx in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beppu, S; Ijichi, K; Kabaya, K; Kawakita, D; Matoba, T; Murakami, S; Torii, J; Yanagi, T | 1 |
| Agüero, A; Farré, N; García, J; León, X; López, M; López-Pousa, A; Quer, M | 1 |
| Hanai, N; Hasegawa, Y; Hirakawa, H; Nakashima, T; Nishikawa, D; Ozawa, T; Suzuki, H | 1 |
| Choi, SH; Kim, JH; Kim, SC; Ryoo, I; Sohn, CH | 1 |
| Berg, S; Boessert, P; Fruth, K; Haxel, BR; Mann, WJ | 1 |
| Bolotina, LV; Kornietskaia, AL | 1 |
| Fietkau, R; Iro, H; Kuwert, T; Lell, M; Lettmaier, S; Schmidt, D; Semrau, S; Waldfahrer, F | 1 |
| Biete Solà, A; Calvo Manuel, FA; de Las Heras González, M; Grau de Castro, JJ; Marruecos Querol, J; Palacios Eito, A; Ramos Aguerri, A; Rovirosa Casino, A; Solano López, MV; Veiras Candal, C; Verger Fransoy, E | 1 |
| Borel, C; Calais, G; Cupissol, D; Eymard, JC; Germann, N; Kohser, F; Labourey, JL; Tourani, JM; Tubiana-Mathieu, N | 1 |
3 trial(s) available for docetaxel anhydrous and Cancer of Pharynx
| Article | Year |
|---|---|
[Induction therapy of locally-advanced nasophayngeal cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Nose Neoplasms; Pharyngeal Neoplasms; Radiotherapy, Adjuvant; Remission Induction; Taxoids; Treatment Outcome | 2011 |
Phase II trial: concurrent radio-chemotherapy with weekly docetaxel for advanced squamous cell carcinoma of head and neck.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Confidence Intervals; Docetaxel; Female; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Karnofsky Performance Status; Laryngeal Neoplasms; Larynx; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Pharyngeal Neoplasms; Pharynx; Radiotherapy; Radiotherapy Dosage; Taxoids; Time Factors; Treatment Outcome | 2007 |
Docetaxel plus gemcitabine in recurrent and/or metastatic squamous cell carcinoma of the head and neck: a phase II multicenter study.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Deoxycytidine; Docetaxel; Female; Gemcitabine; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Pharyngeal Neoplasms; Recurrence; Taxoids; Treatment Outcome | 2007 |
6 other study(ies) available for docetaxel anhydrous and Cancer of Pharynx
| Article | Year |
|---|---|
Chemo-selection with docetaxel, cisplatin and 5-fluorouracil (TPF) regimen followed by radiation therapy or surgery for pharyngeal and laryngeal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Induction Chemotherapy; Laryngeal Neoplasms; Male; Middle Aged; Pharyngeal Neoplasms; Retrospective Studies; Taxoids | 2017 |
Salvage surgery after local recurrence in patients with head and neck carcinoma treated with chemoradiotherapy or bioradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Cohort Studies; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Pharyngeal Neoplasms; Retrospective Studies; Salvage Therapy; Squamous Cell Carcinoma of Head and Neck; Taxoids | 2015 |
Role of induction chemotherapy for N3 head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Case-Control Studies; Chemoradiotherapy; Cisplatin; Cohort Studies; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Laryngeal Neoplasms; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Pharyngeal Neoplasms; Radiotherapy; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taxoids | 2015 |
Squamous Cell Carcinoma of the Head and Neck: Comparison of Diffusion-weighted MRI at b-values of 1,000 and 2,000 s/mm(2) to Predict Response to Induction Chemotherapy.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Diffusion Magnetic Resonance Imaging; Docetaxel; Female; Fluorouracil; Forecasting; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Induction Chemotherapy; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Pharyngeal Neoplasms; Remission Induction; Retrospective Studies; Sensitivity and Specificity; Taxoids; Tumor Burden | 2015 |
Olfaction in chemotherapy for head and neck malignancies.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Cohort Studies; Controlled Before-After Studies; Differential Threshold; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Olfaction Disorders; Pharyngeal Neoplasms; Prospective Studies; Sensory Thresholds; Smoking; Squamous Cell Carcinoma of Head and Neck; Taxoids | 2016 |
Results of chemoselection with short induction chemotherapy followed by chemoradiation or surgery in the treatment of functionally inoperable carcinomas of the pharynx and larynx.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Docetaxel; Endoscopy; Feasibility Studies; Female; Humans; Induction Chemotherapy; Laryngeal Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Organ Sparing Treatments; Pharyngeal Neoplasms; Positron-Emission Tomography; Remission Induction; Salvage Therapy; Survival Rate; Taxoids; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2013 |